Market Overview:
The global preimplantation genetic testing market size reached US$
477.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$
816.3 Million by 2027, exhibiting a growth rate (CAGR) of
9.43% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Preimplantation genetic testing (PGT) identifies abnormal embryos and allows the transfer of genetically normal embryos. It reduces the trauma of multiple failed in vitro fertilization (IVF) cycles and early miscarriages. It also protects children from inherited monogenic disorders. As a result, it is used to treat individuals at high risk of having babies with specific genetic aberrations. It is also utilized in hematological disorders to cure the affected child and in cases of advanced maternal age to avoid the birth of a syndromic child. Nowadays, PGT technology is integrated with Assisted Reproductive Technology (ART) procedures to offer the best outcomes to patients around the world.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Preimplantation Genetic Testing Market Trends:
Chromosomal aneuploidies are one of the leading causes of infertility and maternal age-related reduced fertility. A significant rise in the birth rates and incidences of spontaneous miscarriages represents one of the key factors positively influencing the demand for PGT to reduce the need for multiple IVF cycles. In addition, as the risk of miscarriage grows gradually with the woman’s age, the emerging delayed parenthood trend is catalyzing the demand for PGT across the globe. Apart from this, the rising medical tourism and improving diagnostic modalities are other factors stimulating the market growth. Moreover, the introduction of novel techniques that include microarray and genome sequencing is propelling the market growth. Furthermore, with the discovery of deoxyribonucleic acid (DNA) within the blastocoele fluid (BF) of blastocysts and in spent embryo culture media (SCM), researchers are focusing on developing non-invasive methods of PGT. In confluence with this, the escalating demand for minimally invasive (MI) procedures is contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global preimplantation genetic testing market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, procedure, technology and application.
Breakup by Product:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Reagents and Consumables
- Instruments
Breakup by Procedure:
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
Breakup by Technology:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Fluorescence in Situ Hybridization
- Comparative Genomic Hybridization
- Single-Nucleotide Polymorphism
Breakup by Application:
- Aneuploidy
- Single Gene Disorder
- Structural Chromosomal Abnormalities
- Translocations
- Deletions
- Duplications
- Inversions
- X-Linked Disorders
- Human Leukocyte Typing
- Gender Identification
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, The Cooper Companies Inc and Thermo Fisher Scientific.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Product, Procedure, Technology, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, The Cooper Companies Inc and Thermo Fisher Scientific |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global preimplantation genetic testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global preimplantation genetic testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global preimplantation genetic testing market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Preimplantation Genetic Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents and Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Procedure
7.1 Preimplantation Genetic Screening
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Preimplantation Genetic Diagnosis
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Technology
8.1 Next-Generation Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Fluorescence in Situ Hybridization
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Comparative Genomic Hybridization
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Single-Nucleotide Polymorphism
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Application
9.1 Aneuploidy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Single Gene Disorder
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Structural Chromosomal Abnormalities
9.3.1 Market Trends
9.3.2 Key Segments
9.3.2.1 Translocations
9.3.2.2 Deletions
9.3.2.3 Duplications
9.3.2.4 Inversions
9.3.3 Market Forecast
9.4 X-Linked Disorders
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Human Leukocyte Typing
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Gender Identification
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 F. Hoffmann-La Roche Ltd.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 Illumina Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Laboratory Corporation of America Holdings
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Natera Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Oxford Gene Technology IP Limited (Sysmex Corporation)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 PerkinElmer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Quest Diagnostics Incorporated
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 The Cooper Companies Inc
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Thermo Fisher Scientific
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
List of Figures
Figure 1: Global: Preimplantation Genetic Testing Market: Major Drivers and Challenges
Figure 2: Global: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Preimplantation Genetic Testing Market: Breakup by Product (in %), 2021
Figure 5: Global: Preimplantation Genetic Testing Market: Breakup by Procedure (in %), 2021
Figure 6: Global: Preimplantation Genetic Testing Market: Breakup by Technology (in %), 2021
Figure 7: Global: Preimplantation Genetic Testing Market: Breakup by Application (in %), 2021
Figure 8: Global: Preimplantation Genetic Testing Market: Breakup by Region (in %), 2021
Figure 9: Global: Preimplantation Genetic Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Preimplantation Genetic Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Preimplantation Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Preimplantation Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Preimplantation Genetic Testing (Preimplantation Genetic Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Preimplantation Genetic Testing (Preimplantation Genetic Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Preimplantation Genetic Testing (Preimplantation Genetic Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Preimplantation Genetic Testing (Preimplantation Genetic Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Preimplantation Genetic Testing (Next-Generation Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Preimplantation Genetic Testing (Next-Generation Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Preimplantation Genetic Testing (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Preimplantation Genetic Testing (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Preimplantation Genetic Testing (Fluorescence in Situ Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Preimplantation Genetic Testing (Fluorescence in Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Preimplantation Genetic Testing (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Preimplantation Genetic Testing (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Preimplantation Genetic Testing (Single-Nucleotide Polymorphism) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Preimplantation Genetic Testing (Single-Nucleotide Polymorphism) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Preimplantation Genetic Testing (Aneuploidy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Preimplantation Genetic Testing (Aneuploidy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Preimplantation Genetic Testing (Single Gene Disorder) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Preimplantation Genetic Testing (Single Gene Disorder) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Preimplantation Genetic Testing (Structural Chromosomal Abnormalities) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Preimplantation Genetic Testing (Structural Chromosomal Abnormalities) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Preimplantation Genetic Testing (X-Linked Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Preimplantation Genetic Testing (X-Linked Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Preimplantation Genetic Testing (Human Leukocyte Typing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Preimplantation Genetic Testing (Human Leukocyte Typing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Preimplantation Genetic Testing (Gender Identification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Preimplantation Genetic Testing (Gender Identification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Preimplantation Genetic Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Preimplantation Genetic Testing Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Preimplantation Genetic Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Preimplantation Genetic Testing Industry: SWOT Analysis
Figure 89: Global: Preimplantation Genetic Testing Industry: Value Chain Analysis
Figure 90: Global: Preimplantation Genetic Testing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Preimplantation Genetic Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Preimplantation Genetic Testing Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Preimplantation Genetic Testing Market Forecast: Breakup by Procedure (in Million US$), 2022-2027
Table 4: Global: Preimplantation Genetic Testing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Preimplantation Genetic Testing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Preimplantation Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Preimplantation Genetic Testing Market: Competitive Structure
Table 8: Global: Preimplantation Genetic Testing Market: Key Players